RADX
Radiopharm·NASDAQ
--
--(--)
--
--(--)
RADX Filings
Filing Date
Form Description
Form Type
2026-01-28
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-28 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-16
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-16 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-12 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-08
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-08 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-29
Form EFFECT - Notice of Effectiveness
2025-12-29 ·
Form EFFECT - Notice of Effectiveness
2025-12-29
Form EFFECT - Notice of Effectiveness
2025-12-29 ·
Form EFFECT - Notice of Effectiveness
2025-12-23
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-23 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-23
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-23 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-17
Form F-3 - Registration statement by foreign private issuers
2025-12-17 ·
Form F-3 - Registration statement by foreign private issuers
